Biogen (BIIB) Income from Continuing Operations (2009 - 2026)
Biogen's Income from Continuing Operations was -$20.6 million in Q3 2026, compared with $466.5 million a year earlier.
Powered by 
Analysis
Biogen (BIIB) Income from Continuing Operations (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Biogen's Income from Continuing Operations was $347.5 million through Sep 30, 2026, down 78.4% year-over-year; for FY2025, it came in at $1.29 billion, down 20.8% from FY2024.
- Income from Continuing Operations shows a five-year compound annual growth rate of -20.4% (FY2020 to FY2025).
- In earlier years, Income from Continuing Operations was $1.63 billion in FY2024 (+40.5%), $1.16 billion in FY2023 (-60.7%), $2.96 billion in FY2022 (+74.8%) and $1.69 billion in FY2021 (-58.3%).
- Quarterly Income from Continuing Operations has moved between -$68.3 million (Q3 2023) and $1.13 billion (Q3 2022) over five years.
- Compared with a year earlier, Income from Continuing Operations was higher in four of the last six quarters, with an average decline of 9.1%.
- The best year-over-year quarter for Income from Continuing Operations over five years was Q3 2022 (growth of 258.0%); the worst was Q2 2026 (a decline of 84.6%).
- Per Business Quant data, BIIB's Income from Continuing Operations in the three quarters before Q3 2026 was $97.5 million (Q2 2026), $319.5 million (Q1 2026) and -$48.9 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | -20.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -20.60 Mn |
| Jun 30, 2026 | 97.50 Mn |
| Mar 31, 2026 | 319.50 Mn |
| Dec 31, 2025 | -48.90 Mn |
| Sep 30, 2025 | 466.50 Mn |
| Jun 30, 2025 | 634.80 Mn |
| Mar 31, 2025 | 240.50 Mn |
| Dec 31, 2024 | 266.70 Mn |
| Sep 30, 2024 | 388.50 Mn |
| Jun 30, 2024 | 583.60 Mn |
| Mar 31, 2024 | 393.40 Mn |
| Dec 31, 2023 | 248.90 Mn |
| Sep 30, 2023 | -68.30 Mn |
| Jun 30, 2023 | 593.30 Mn |
| Mar 31, 2023 | 387.60 Mn |
| Dec 31, 2022 | 549.50 Mn |
| Sep 30, 2022 | 1.13 Bn |
| Jun 30, 2022 | 1.05 Bn |
| Mar 31, 2022 | 221.80 Mn |
| Dec 31, 2021 | -38.20 Mn |
API Access
Biogen Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();